1
Clinical Trials associated with Cancer vaccine(BlueWillow Biologics)An open-label, single-arm study evaluating the safety and efficacy of oral cancer vaccine B440 in PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer - oral cancer vaccine B440
Start Date19 Jan 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with Cancer vaccine(BlueWillow Biologics)
100 Translational Medicine associated with Cancer vaccine(BlueWillow Biologics)
100 Patents (Medical) associated with Cancer vaccine(BlueWillow Biologics)
2
Literatures (Medical) associated with Cancer vaccine(BlueWillow Biologics)01 Jan 2018·Biologie Aujourd'hui
Vaccins anti-cancer : quel avenir dans les stratégies d’immunothérapie anti-cancéreuse ?
Review
Author: Tartour, Eric
British Journal of Cancer
Review
Author: Dalgleish, A G
100 Deals associated with Cancer vaccine(BlueWillow Biologics)